| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000024356 |
| Receipt No. | R000027732 |
| Official scientific title of the study | A study on the effect of functional food containing beverage on blood glucose level in human. |
| Date of disclosure of the study information | 2016/10/16 |
| Last modified on | 2016/10/11 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | A study on the effect of functional food containing beverage on blood glucose level in human. | |
| Title of the study (Brief title) | A study on the effect of functional food containing beverage on blood glucose level in human. | |
| Region |
|
|
| Condition | |||
| Condition | Not applicable | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To confirm the effect of functional food containing beverage on blood glucose increase. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Efficacy : Area under the curve of delta blood glucose level.
Safety : Incidence of adverse effects |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Subjects take a can of two kinds of functional foods containing beverage once in a day. After 6-days washout, subjects take a can of placebo beverage once in a day. After 6-days washout, subjects take a can of one kind of functional food containing beverage once in a day. In each time, subjects take 300g of rice 30mins after beverage intake. | |
| Interventions/Control_2 | Subjects take a can of one kind of functional food containing beverage once in a day. After 6-days washout, subjects take a can of two kinds of functional foods containing beverage once in a day. After 6-days washout, subjects take a can of placebo beverage once in a day. In each time, subjects take 300g of rice 30mins after beverage intake. | |
| Interventions/Control_3 | Subjects take a can of placebo beverage once in a day. After 6-days washout, subjects take a can of one kind of functional food containing beverage once in a day. After 6-days washout, subjects take a can of two kinds of functional foods containing beverage once in a day. In each time, subjects take 300g of rice 30mins after beverage intake. | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Healthy males aged 20 or more and less than 65 years-old.
2)Subjects with fasting blood glucose level 100 mg/dL or more and less than 126 mg/dL 3)Subjects who can visit hospital on designated day. 4)Subjects giving written informed consent. |
|||
| Key exclusion criteria | 1)Subjects with constant drug treatment.
2)Subjects who are contracting diabetes. 3)Subjects who constantly use supplements and/or functional foods (including Food for Specified Health Uses) affecting the test results. 4)Subjects with a previous history of disease on heart, liver, kidney or digestive organs. 5)Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating. 6)Subjects who drink alcohol a lot and smoke a lot. 7)Subjects who have an irregular sleep cycle, work shift or work on midnight shift. 8)Subjects who have allergic reaction to drug medicine and food. 9)Subjects whose systolic blood pressure is less than 90mmHg. 10)Subjects who donated 200 mL of blood and/or blood components within four weeks prior to the current study. 11)Male subjects whose blood was collected more than 400 mL within the last twelve weeks. 12)Female subjects whose blood was collected more than 400 mL within the last sixteen weeks. 13)Male subjects whose blood was collected more than 1200 mL within the last twelve months when the amount of blood sampling in the current study is added. 14)Female subjects whose blood was collected more than 800 mL within the last twelve months when the amount of blood sampling in the current study is added. 15)Subjects who are participating in other clinical studies for drug medicine or food, or who finished clinical study within four weeks. 16)Subjects who are judged as unsuitable for the study by the principal investigator for other reasons. |
|||
| Target sample size | 21 | |||
| Research contact person | |
| Name of lead principal investigator | Norihito Murayama |
| Organization | Suntory Global Innovation Center Ltd. |
| Division name | Innovation Development Department |
| Address | 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto 619-0284, Japan |
| TEL | 050-3182-0588 |
| Norihito_Murayama@suntory.co.jp | |
| Public contact | |
| Name of contact person | Hiroshi Watanabe |
| Organization | Suntory Global Innovation Center Ltd. |
| Division name | Innovation Development Department |
| Address | 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto 619-0284, Japan |
| TEL | 050-3182-0593 |
| Homepage URL | |
| H_Watanabe@suntory.co.jp | |
| Sponsor | |
| Institute | Suntory Global Innovation Center Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Suntory Global Innovation Center Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 医療法人社団慈昂会 福住内科クリニック (北海道) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027732 |